News

Ulvera AI Welcomes Domenic Serafino as New CEO and Co-Founder

Ulvera AI Welcomes Domenic Serafino as New CEO and Co-Founder

Ulvera AI Names Domenic Serafino as CEO and Co-Founder

Ulvera AI has announced the exciting appointment of Domenic Serafino to the position of Chief Executive Officer and Co-Founder. With over three decades of rich experience in the medical aesthetics industry, Mr. Serafino is poised to lead the company into a new era of growth and innovation.

Remarkable Leadership Journey

Mr. Serafino’s illustrious career includes co-founding Venus Concept Inc. in 2010, where he served as CEO until 2022. Under his leadership, Venus Concept transformed from a mere startup to a robust company, achieving over $120 million in annual revenues. His past experiences also include significant roles at Syneron Medical Corp, where he was integral to the company’s successful IPO in 2004, achieving a remarkable market cap of $1.4 billion within just 18 months.

Vision for Ulvera AI

Expressing his excitement about this new role, Mr. Serafino stated, "I am honored to join Ulvera AI as its CEO and Co-Founder. Ulvera AI's dedication to pioneering aesthetic medical technologies is truly commendable. After researching and working with various technologies over the years, I am confident that the team at Ulvera AI has developed something groundbreaking within the non-invasive body contouring market." His appointment is seen as a vital step in propelling the company forward.

Innovative Body Contouring Technology

At the core of Ulvera AI’s offerings is a cutting-edge body contouring technology that delivers multi-layered treatments through a combination of ultrasound and electric muscle stimulation (EMS). Tailored treatments are formulated based on ultrasound imaging to optimize patient outcomes. This technology targets several layers of body tissue, having shown impressive clinical results such as a fat layer thickness reduction between 18% and 27%, averaging around 23%.

Expert Endorsements

Notably, Dr. Grant Stevens shared his enthusiasm about working alongside Mr. Serafino, emphasizing the exciting potential of this innovative body contouring technology. He commented, "We finally have a comfortable way to precisely target the stubborn fat bulges and tighten skin safely and economically," underscoring the comfortable nature of the treatment.

A Transformative Move for Ulvera AI

Dr. Ines Verner, Co-Founder and President of Ulvera AI, conveyed her enthusiasm for Mr. Serafino’s appointment, stating, "Welcoming Dom as CEO and Co-Founder is a transformational step for Ulvera AI. His visionary leadership and unparalleled expertise in the aesthetics medical device arena perfectly align with our ambitious goals. We are thrilled to have him lead our team and are eager to leverage his insights to enhance our innovative vision." This clearly depicts the excitement surrounding Mr. Serafino’s arrival.

About Ulvera AI

Ulvera AI is an innovative startup based in Israel, specializing in advanced non-invasive body contouring solutions within the aesthetic medical market. Aiming to provide personalized treatments based on individual patient needs, Ulvera AI stands as a significant player in the field.

Contact Information

For media inquiries, please contact Dr. Ines Verner, Co-Founder of Ulvera AI. She can be reached directly at a phone number, +972-52-6544600.

Frequently Asked Questions

What is the significance of Domenic Serafino's appointment?

Domenic Serafino's appointment represents a pivotal moment for Ulvera AI, bringing extensive experience and leadership in the medical aesthetics sector.

What technologies does Ulvera AI specialize in?

Ulvera AI focuses on non-invasive body contouring technologies, which utilize ultrasound and electric muscle stimulation for effective treatments.

How does Ulvera AI's technology work?

The company’s technology provides personalized body contouring treatments based on ultrasound imaging, effectively targeting various layers of fat and muscle.

What past achievements does Domenic Serafino have?

Before joining Ulvera AI, Domenic Serafino co-founded Venus Concept Inc. and contributed to Syneron Medical Corp's successful IPO.

How does Ulvera AI aim to serve its patients?

Ulvera AI is committed to treating each patient according to their unique needs, offering tailored aesthetic solutions for body contouring.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Michelle T. Boone's Impactful Tenure at Poetry Foundation

Updated Category News Views 21

When Michelle T. Boone took the helm of the Poetry Foundation back in May 2021, the nonprofit world, much like the rest of us, was living through unprecedented times. Even then, Boone wasn't one to shy away from a challenge. Spotting opportunities when others see chaos is a talent most seasoned leaders possess, and Boone demonstrated just that by nudging the Foundation...

Continue Reading
Niron Magnetics Shakes Up CES with Rare-Earth-Free Tech

Updated Category News Views 47

Breaking the Mold with Iron Nitride Niron Magnetics ain’t your average player in the magnet game, and they’ve got their eyes locked on the CES 2027 spotlight. This upstart from Minneapolis just snagged a CES Innovation Award in Vehicle Tech & Advanced Mobility. So, forget the usual rare-earth shuffle: Niron's Iron Nitride magnets are rewriting the rules, striding into...

Continue Reading
Lawyers Juggle AI's Promise and Perils in 2026

Updated Category News Views 82

AI's Growing Pains in the Legal Arena Looks like the legal eagles are getting a run for their money with AI entering the courtroom. Bloomberg Law's 2026 AI in Practice report dives deep into this legal labyrinth. You got attorneys leaning on AI to keep the gears turning, but they're also clutching their pearls over potential pitfalls. Trust Issues: Humans vs. Machines The...

Continue Reading
AptarGroup Faces Investigation: Shareholder Stakes High

Updated Category News Views 89

AptarGroup Directors Under Investigation Every seasoned investor knows the market isn’t just sunshine and rainbows. Lately, the storm clouds have gathered over AptarGroup, Inc. (NYSE: ATR). Out of nowhere comes Purcell & Lefkowitz LLP, announcing a shareholder investigation that sends shivers down the spines of those who've put their money on this packaging...

Continue Reading
Cell Counting Market Growth: USD 17.71 Billion by 2031

Updated Category News Views 140

The Cell Counting Surge: Money Talks in Science You can't deny it when the numbers speak—a jump from USD 12.39 billion to USD 17.71 billion by 2031 in the cell counting market means something ain't business as usual. That's a robust 7.40% CAGR folks; it's a field being bombarded with innovation. The spark? Automated and advanced cell analysis technology taking the...

Continue Reading
Fibocom & GridCrest Unveil Smart Meter Tech at Enlit

Updated Category News Views 55

A Bright Future for Smart Meter Technology Revealed Some days look drearier than others in the tech game, but not this one. Fibocom and GridCrest just showcased their latest collaboration at Enlit Europe 2026 in Vienna, and it paints a pretty sparkling future for smart electricity meters. We're talking about the ME260 single-phase smart meter that promises to be a...

Continue Reading
Kemin Unveils LYSOFORTE ENFUSIO at EuroTier 2026

Updated Category News Views 158

Rollin' up to EuroTier 2026 with all its buzz—a place where big players in livestock production flex their muscles—Kemin Industries dropped a new ace in the feed deck: LYSOFORTE ENFUSIO. They're betting this bad boy will shake things up for poultry and pig nutritionists looking to maximize what's already on their plate without piling on more grain or feed costs....

Continue Reading
Hi Peach Layne Rides Trend with New Hair Repair Oil

Updated Category News Views 23

Diving into Beauty Economics with Walmart Now here's a story that ticks every box in the bargain bin playbook—Hi Peach Layne's latest move into the haircare aisle. They're launching a Hair Repair Oil loaded with claims that shout 'value!' loud enough to echo down a Walmart aisle. With a price point of $9.97, it's sliding right into Walmart's "Beauty Finds Under $10"...

Continue Reading
Burtch Works Joins Databricks: Fueling AI Success

Updated Category News Views 94

Game-Changer for AI Talent Market First off, let me tell you, in this data-driven world, finding solid AI talent is like hitting the jackpot. Burtch Works teaming up with Databricks? That's like leaping into a goldmine fully prepared. We're talking about forward-deployed engineers and specialized AI talent coming straight to your door. Closing the Impossible Talent Gap...

Continue Reading
Envista's $430M Senior Notes: A Market Move Decoded

Updated Category News Views 58

Envista on the Move with $430M Notes Ever feel like the market's a bit like a rollercoaster with no brakes? That's kind of where we're at with Envista Holdings Corporation (NYSE: NVST) rolling out this new financial play. They just priced a hefty $430 million in Senior Notes at a solid 6.250% due 2033. In terms of the investment world, that's a pretty big splash. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Explore the New Bond Terms for Nykredit Realkredit A/S

Updated Category News Views 200

New Bond Terms for Nykredit Realkredit A/S Nykredit Realkredit A/S is initiating new bonds in connection with the opening of fresh ISINs under its Base Prospectus. These new Final Bond Terms come as part of the bank's ongoing efforts to optimize its financial structure, and they will be vital for investors to understand as they navigate the bond market. The established...

Continue Reading
Catalyst Power Expands Services to Enhance Energy Solutions

Updated Category News Views 190

Empowering New Approaches to Energy Management Catalyst Power offers tailored energy solutions for businesses. Catalyst Power Holdings LLC, an independent provider of retail energy solutions for large commercial and industrial customers, is excited to announce the launch of its retail electricity services. The initiative focuses particularly on assisting businesses in...

Continue Reading
Understanding Fidelity National Info Inc's Current Market Position

Updated Category News Views 344

Analyzing Fidelity National Info Inc's Stock Performance At present, the share price of Fidelity National Info Inc. (FIS) stands at $70.51, reflecting a modest increase of 1.82% in the current market session. While the stock experienced a 13.45% decline over the last month, it has shown a slight rise of 1.53% within the past year. This performance may prompt investors to...

Continue Reading
Shell plc’s Share Buy-Back Developments: A Detailed Overview

Updated Category News Views 119

Overview of Shell plc's Share Buy-Back Initiatives Shell plc, a global leader in the energy sector, has announced significant updates regarding its share buy-back programme. This initiative has been designed to enhance shareholder value through strategic management of its capital. Recently, Shell made a notable purchase of its own shares, marking a substantial step in its...

Continue Reading
Akeso's Ivonescimab Sets New Standards in NSCLC Treatment

Updated Category News Views 164

Akeso's Groundbreaking Clinical Trial Results Akeso, Inc. (9926.HK) is thrilled to share significant breakthroughs from its Phase III clinical study of ivonescimab, a cutting-edge PD-1/VEGF bispecific antibody designed to treat non-small cell lung cancer (NSCLC). The study, known as HARMONi-2/AK112-303, has garnered attention following its publication in The Lancet, one...

Continue Reading